A National Phase II Study of Proton Therapy in Hepatocellular Carcinoma

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

January 1, 2030

Conditions
Hepatocellular Carcinoma
Interventions
RADIATION

Proton therapy

All patients will receive proton therapy 67.5Gy/15fx

Trial Locations (3)

2730

RECRUITING

Herlev Hospital, Herlev

5000

NOT_YET_RECRUITING

Odense University Hospital, Odense

8200

RECRUITING

Aarhus University Hospital, Aarhus

All Listed Sponsors
collaborator

Herlev Hospital

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

University of Leeds

OTHER

collaborator

Aarhus University Hospital

OTHER

lead

University of Aarhus

OTHER